bpc-157 dosage for humans dosing protocol human BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved BPC-157 Dosage: A Complete Guide
Description
Scale is defined by bioavailability , not quantity
Gay CM, Stewart CA, Park EM, Diao L, Groves SM, Heeke S, et al
Every injection is administered by licensed medical professionals and personalized to your goals
For pain-free and safe injections, we recommend using our insulin needles and bacteriostatic water
